These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 22122488)

  • 1. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal adverse effects of injected ceftriaxone sodium in China.
    Yao Y; Zhou R; Wang Y
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1197-201. PubMed ID: 22761158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.
    Bradley JS; Wassel RT; Lee L; Nambiar S
    Pediatrics; 2009 Apr; 123(4):e609-13. PubMed ID: 19289450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children.
    Atanasković-Marković M; Velicković TC; Gavrović-Jankulović M; Vucković O; Nestorović B
    Pediatr Allergy Immunol; 2005 Jun; 16(4):341-7. PubMed ID: 15943598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab infusion reactions: French pharmacovigilance database analysis.
    Grandvuillemin A; Disson-Dautriche A; Miremont-Salamé G; Fourrier-Reglat A; Sgro C;
    J Oncol Pharm Pract; 2013 Jun; 19(2):130-7. PubMed ID: 23154574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF).
    Salvo F; Polimeni G; Cutroneo PM; Leone R; Confortic A; Moretti U; Motola D; Tuccori M; Caputi AP
    Pharmacol Res; 2008; 58(3-4):202-7. PubMed ID: 18692136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there cross-reactivity between penicillins and cephalosporins?
    Apter AJ; Kinman JL; Bilker WB; Herlim M; Margolis DJ; Lautenbach E; Hennessy S; Strom BL
    Am J Med; 2006 Apr; 119(4):354.e11-9. PubMed ID: 16564780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety evaluation of cephalosporins based on utilization and adverse drug events: analysis of two databases in China.
    Ren X; Liu D; Ding N; Huang K; Xiong Y; Du G; Zeng F
    Expert Opin Drug Saf; 2012 Sep; 11(5):689-97. PubMed ID: 22708900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
    Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.